{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:08:36Z","timestamp":1792494516978,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004721","name":"Todai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114274","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:37:37Z","timestamp":1758940657000},"page":"114274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Glycoliposomes target lymphatic dendritic cells in a size-dependent manner to activate natural killer T cells against breast tumors"],"prefix":"10.1016","volume":"388","author":[{"given":"Taehun","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Umezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114274_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01178","article-title":"Natural killer T cells in cancer immunotherapy","volume":"8","author":"Nair","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0015","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ni1203-1164","article-title":"The NKT cell system: bridging innate and acquired immunity","volume":"4","author":"Taniguchi","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.995562","article-title":"Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice","volume":"4","author":"Gebremeskel","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jconrel.2025.114274_bb0025","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.4049\/jimmunol.167.6.3114","article-title":"Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK Cells1","volume":"167","author":"Metelitsa","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0030","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1158\/0008-5472.CAN-18-0734","article-title":"Activation of NKT cells in an anti-PD-1\u2013resistant tumor model enhances antitumor immunity by reinvigorating exhausted CD8 T cells","volume":"78","author":"Bae","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114274_bb0035","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0040","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of V\u03b114 NKT cells by Glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114274_bb0045","first-page":"3702","article-title":"A phase I study of the natural killer T-cell ligand \u03b1-Galactosylceramide (KRN7000) in patients with solid tumors","volume":"8","author":"Giaccone","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114274_bb0050","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1158\/1078-0432.CCR-06-0114","article-title":"A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non\u2013small cell lung cancer","volume":"12","author":"Motohashi","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114274_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ijc.10678","article-title":"Preserved IFN-\u03b1 production of circulating V\u03b124 NKT cells in primary lung cancer patients","volume":"102","author":"Motohashi","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114274_bb0060","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1172\/JCI26297","article-title":"Activation or anergy: NKT cells are stunned by \u03b1-galactosylceramide","volume":"115","author":"Sullivan","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114274_bb0065","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI24762","article-title":"Glycolipid antigen induces long-term natural killer T cell anergy in mice","volume":"115","author":"Parekh","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114274_bb0070","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1349-7006.2009.01135.x","article-title":"Combination therapy of in vitro-expanded natural killer T cells and \u03b1-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma","volume":"100","author":"Kunii","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2025.114274_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000316","article-title":"Phase II study of \u03b1-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer","volume":"8","author":"Toyoda","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114274_bb0080","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/1078-0432.CCR-04-1453","article-title":"A phase I study of \u03b1-galactosylceramide (KRN7000)\u2013pulsed dendritic cells in patients with advanced and recurrent non\u2013small cell lung cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114274_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01838","article-title":"Tissue-specific roles of NKT cells in tumor immunity","volume":"9","author":"Terabe","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0090","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI200423594","article-title":"Going both ways: immune regulation via CD1d-dependent NKT cells","volume":"114","author":"Godfrey","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114274_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/82698","article-title":"NKT cells and tumor immunity\u2014a double-edged sword","volume":"1","author":"Smyth","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0100","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.180.6.3627","article-title":"NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis1","volume":"180","author":"Berzofsky","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0105","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1182\/blood-2007-05-092866","article-title":"Type I NKT cells protect (and type II NKT cells suppress) the host\u2019s innate antitumor immune response to a B-cell lymphoma","volume":"111","author":"Renukaradhya","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.114274_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01858","article-title":"Natural killer T cells: an ecological evolutionary developmental biology perspective","volume":"8","author":"Kumar","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0115","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20050953","article-title":"Differential antitumor immunity mediated by NKT cell subsets in vivo","volume":"202","author":"Crowe","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114274_bb0120","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.4049\/jimmunol.0901059","article-title":"Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor \u03b3t+ and respond preferentially under inflammatory Conditions1","volume":"183","author":"Doisne","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1189\/jlb.69.5.741","article-title":"Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation","volume":"69","author":"Wang","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.168.4.1519","article-title":"Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver","volume":"168","author":"Exley","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0135","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20051381","article-title":"A nonclassical non-V\u03b114J\u03b118 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance","volume":"202","author":"Terabe","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114274_bb0140","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.4049\/jimmunol.167.10.5531","article-title":"Cutting edge: a major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte Responses1","volume":"167","author":"Exley","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1084\/jem.190.9.1215","article-title":"Cd1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site","volume":"190","author":"Sonoda","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114274_bb0150","unstructured":"Regulation of Adaptive Immune Responses by Innate Cells Expressing NK Markers and Antigen-Transporting Macrophages - Stein-Streilein - 2000 - Journal of Leukocyte Biology Wiley Online Library, (n.d.). https:\/\/jlb.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jlb.67.4.488 (accessed March 4, 2025)."},{"key":"10.1016\/j.jconrel.2025.114274_bb0155","doi-asserted-by":"crossref","first-page":"21778","DOI":"10.1038\/s41598-020-78688-2","article-title":"NKT cells promote both type 1 and type 2 inflammatory responses in a mouse model of liver fibrosis","volume":"10","author":"Nilsson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114274_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.166.1.313","article-title":"MIP-2 recruits NKT cells to the spleen during tolerance Induction1","volume":"166","author":"Faunce","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0165","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/s41467-022-30759-w","article-title":"Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity","volume":"13","author":"Umeshappa","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114274_bb0170","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4049\/jimmunol.1002725","article-title":"Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1\u2212 invariant NKT cells to Bacteria","volume":"186","author":"Doisne","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0175","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.4049\/jimmunol.0903730","article-title":"Secretion of IFN-\u03b3 but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen","volume":"184","author":"Mattarollo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0180","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.4049\/jimmunol.0900134","article-title":"Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic Cells1","volume":"182","author":"Tripp","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303690","article-title":"Uplifting antitumor immunotherapy with lymph-node-targeted and ratio-controlled Codelivery of tumor cell lysate and adjuvant","volume":"13","author":"Cui","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114274_bb0190","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1172\/JCI79915","article-title":"Nanoparticulate STING agonists are potent lymph node\u2013targeted vaccine adjuvants","volume":"125","author":"Hanson","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114274_bb0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.03.034","article-title":"Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity","volume":"130","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114274_bb0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/pharmaceutics15020565","article-title":"Nanoparticles for lymph node-directed delivery","volume":"15","author":"Lee","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114274_bb0205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2020.06.003","article-title":"Dawn of lipid nanoparticles in lymph node targeting: potential in cancer immunotherapy","volume":"167","author":"Nakamura","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114274_bb0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2019.09.005","article-title":"Physical and chemical profiles of nanoparticles for lymphatic targeting","volume":"151\u2013152","author":"Ke","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114274_bb0215","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1021\/acs.nanolett.9b02834","article-title":"Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114274_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2008.09.078","article-title":"Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway","volume":"133","author":"Inoue","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114274_bb0225","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1039\/c0ob00975j","article-title":"The stimulating adventure of KRN 7000","volume":"9","author":"Banchet-Cadeddu","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2025.114274_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01206","article-title":"Natural killer T cell-targeted immunotherapy mediating long-term memory responses and strong antitumor activity","volume":"8","author":"Dashtsoodol","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0235","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41598-024-82228-7","article-title":"Characterization and in vitro anticancer study of PEGylated liposome dually loaded with ferulic acid and doxorubicin","volume":"15","author":"Miatmoko","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114274_bb0240","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.09.047","article-title":"A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy","volume":"551","author":"Farzaneh","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114274_bb0245","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","article-title":"Methods of liposomes preparation: formation and control factors of versatile Nanocarriers for biomedical and nanomedicine application","volume":"14","author":"Lombardo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114274_bb0250","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1016\/j.vaccine.2004.01.071","article-title":"Induction of antigen-dependent interleukin-12 production by negatively charged liposomes encapsulating antigens","volume":"22","author":"Yotsumoto","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114274_bb0255","first-page":"922","article-title":"Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB\/c mice","volume":"22","author":"Mehravaran","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.jconrel.2025.114274_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.112649","article-title":"PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: in vitro and in vivo assessment","volume":"303","author":"Singh","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2025.114274_bb0265","doi-asserted-by":"crossref","first-page":"14.44.1","DOI":"10.1002\/cpim.43","article-title":"Liposome preparation for the analysis of lipid-receptor interaction and efferocytosis","volume":"120","author":"Voss","year":"2018","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0270","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/nano9050719","article-title":"PEG-poly(1-methyl-l-tryptophan)-based polymeric micelles as enzymatically activated inhibitors of Indoleamine 2,3-dioxygenase","volume":"9","author":"Huang","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2025.114274_bb0275","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/acsmacrolett.1c00643","article-title":"Microglial Immunoregulation by apoptotic cellular membrane mimetic polymeric particles","volume":"11","author":"Nakagawa","year":"2022","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.jconrel.2025.114274_bb0280","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/14686996.2021.1976055","article-title":"Block catiomer with flexible cationic segment enhances complexation with siRNA and the delivery performance in vitro","volume":"22","author":"Yang","year":"2021","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114274_bb0285","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/acs.molpharmaceut.9b01182","article-title":"The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution","volume":"17","author":"Nakamura","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114274_bb0290","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114274_bb0300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gt.2011.17","article-title":"Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation","volume":"18","author":"Diken","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114274_bb0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/membranes10080177","article-title":"Macropinocytosis in different cell types: similarities and differences","volume":"10","author":"Lin","year":"2020","journal-title":"Membranes"},{"key":"10.1016\/j.jconrel.2025.114274_bb0310","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/pharmaceutics14081572","article-title":"mRNA-loaded lipid nanoparticles targeting dendritic cells for Cancer immunotherapy","volume":"14","author":"Sasaki","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114274_bb0315","doi-asserted-by":"crossref","unstructured":"T. Nishimura, H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, M. Taniguchi, M. Nakui, M. Sekimoto, T. Koda, The Interface between Innate and Acquired Immunity: Glycolipid Antigen Presentation by CD1d-Expressing Dendritic Cells to NKT Cells Induces the Differentiation of Antigen-Specific Cytotoxic T Lymphocytes, (n.d.). doi:https:\/\/doi.org\/10.1093\/intimm\/12.7.987 (accessed March 12, 2025).","DOI":"10.1093\/intimm\/12.7.987"},{"key":"10.1016\/j.jconrel.2025.114274_bb0325","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast cancer immunotherapy: facts and hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114274_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108707","article-title":"The efficacy of PD-1\/PD-L1 blockade in cold cancers and future perspectives","volume":"226","author":"Majidpoor","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114274_bb0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/cancers15010104","article-title":"Mechanisms and strategies to overcome PD-1\/PD-L1 blockade resistance in triple-negative breast Cancer","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2025.114274_bb0345","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the Design of Liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2025.114274_bb0350","first-page":"429","article-title":"Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): effects on hematopoiesis and serum IL-6 levels","volume":"24","author":"Rollwagen","year":"1996","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0355","first-page":"670","article-title":"Toxicity of sphingomyelin-containing liposomes after chronic injection into mice","volume":"64","author":"Weereratne","year":"1983","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0360","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114274_bb0365","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114274_bb0370","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1016\/j.actbio.2013.06.010","article-title":"Size effect of amphiphilic poly(\u03b3-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo","volume":"9","author":"Shima","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114274_bb0375","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1172\/JCI72308","article-title":"IL-10\u2013producing NKT10 cells are a distinct regulatory invariant NKT cell subset","volume":"124","author":"Sag","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114274_bb0380","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni827","article-title":"Prolonged IFN-\u03b3\u2013producing NKT response induced with \u03b1-galactosylceramide\u2013loaded DCs","volume":"3","author":"Fujii","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0390","doi-asserted-by":"crossref","first-page":"17847","DOI":"10.1073\/pnas.0904078106","article-title":"Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1","volume":"106","author":"Kojo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.114274_bb0395","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/intimm\/dxq444","article-title":"Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation","volume":"22","author":"Iyoda","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0400","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.20050810","article-title":"Dendritic cell maturation by innate lymphocytes\u00a0: coordinated stimulation of innate and adaptive immunity","volume":"202","author":"M\u00fcnz","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114274_bb0405","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20030324","article-title":"Activation of natural killer T cells by \u03b1-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein","volume":"198","author":"Fujii","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114274_bb0410","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","article-title":"Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK Cells1","volume":"163","author":"Carnaud","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0420","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/eji.200737660","article-title":"Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania","volume":"38","author":"Dondji","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0425","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s40425-019-0697-7","article-title":"Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor","volume":"7","author":"Paul","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114274_bb0430","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1189\/jlb.0705421","article-title":"Comparative gene expression analysis of NKT cell subpopulations","volume":"80","author":"Lin","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0435","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1172\/JCI59535","article-title":"IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity","volume":"122","author":"Liu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114274_bb0440","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3389\/fimmu.2020.02043","article-title":"Targeted co-delivery of tumor antigen and \u03b1-Galactosylceramide to CD141+ dendritic cells induces a potent tumor antigen-specific human CD8+ T cell response in human immune system mice","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0445","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4049\/jimmunol.1303029","article-title":"Targeted delivery of \u03b1-galactosylceramide to CD8\u03b1+ dendritic cells optimizes type I NKT cell\u2013based antitumor responses","volume":"193","author":"Macho-Fernandez","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0450","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.vaccine.2009.01.047","article-title":"Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy","volume":"27","author":"Thapa","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114274_bb0455","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/vaccines9010056","article-title":"Liposomal nanovaccine containing \u03b1-galactosylceramide and ganglioside GM3 stimulates robust CD8+ T cell responses via CD169+ macrophages and cDC1","volume":"9","author":"Grabowska","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2025.114274_bb0460","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1073\/pnas.1219888110","article-title":"Targeted delivery of lipid antigen to macrophages via the CD169\/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation","volume":"110","author":"Kawasaki","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114274_bb0465","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.intimp.2013.03.009","article-title":"Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes","volume":"15","author":"Ishii","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0470","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2013.07.004","article-title":"The nanoparticulation by octaarginine-modified liposome improves \u03b1-galactosylceramide-mediated antitumor therapy via systemic administration","volume":"171","author":"Nakamura","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114274_bb0475","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1016\/j.vaccine.2015.08.083","article-title":"Synthetic TRP2 long-peptide and \u03b1-galactosylceramide formulated into cationic liposomes elicit CD8+ T-cell responses and prevent tumour progression","volume":"33","author":"Neumann","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114274_bb0480","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.alit.2019.02.003","article-title":"Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis","volume":"68","author":"Suzuki","year":"2019","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jconrel.2025.114274_bb0485","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3389\/fimmu.2018.01496","article-title":"Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell response","volume":"9","author":"Sartorius","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114274_bb0490","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1021\/acsomega.9b00489","article-title":"Codelivery of mRNA with \u03b1-Galactosylceramide using a new Lipopolyplex formulation induces a strong antitumor response upon intravenous administration","volume":"4","author":"Guevara","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2025.114274_bb0495","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1068493","article-title":"Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses","volume":"5","author":"D\u00f6len","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2025.114274_bb0505","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-18-0306","article-title":"Nanoparticles that reshape the tumor milieu create a therapeutic window for effective T cell therapy in solid malignancies","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T13:57:58Z","timestamp":1769867878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":97,"alternative-id":["S0168365925008879"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114274","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoliposomes target lymphatic dendritic cells in a size-dependent manner to activate natural killer T cells against breast tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114274"}}